Shopping Cart
- Remove All
Your shopping cart is currently empty
MLKL-IN-2
🥰Excellent
Catalog No. T41027Cas No. 899759-16-1
MLKL-IN-2 is an MLKL inhibitor with potential tumorigenic activity for the study of cellular necrosis-related diseases.
MLKL-IN-2
🥰Excellent
Purity: 98.61%
Catalog No. T41027Cas No. 899759-16-1
MLKL-IN-2 is an MLKL inhibitor with potential tumorigenic activity for the study of cellular necrosis-related diseases.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $84 | In Stock | |
| 5 mg | $198 | In Stock | |
| 10 mg | $328 | In Stock | |
| 25 mg | $679 | In Stock | |
| 50 mg | $1,070 | In Stock | |
| 100 mg | $1,650 | In Stock | |
| 200 mg | $2,230 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "MLKL-IN-2"
LY-364947
Cited
LY 364947, HTS466284
T2048396129-53-6
LY-364947 (HTS466284) is a potent ATP-competitive inhibitor of TGFβR-I.
- $59
Size
QTY
CitedNecrosulfonamide Cited
(E)-Necrosulfonamide
T69041360614-48-7
(E)-Necrosulfonamide ((E)-Necrosulfonamide) is an inhibitor of necroptosis. Blocks mixed lineage kinase domain-like protein (MLKL), a critical substrate of receptor-interacting serine-threonine kinase 3 (RIP3) during necrosis. Prevents MLKL-RIP1-RIP3 necrosome complex from interacting with downstream necrosis effectors. Binds and inhibits gasdermin D. Inhibits pyroptosis.
- $52
Size
QTY
CitedCerdulatinib hydrochloride
PRT2070 hydrochloride, PRT062070 hydrochloride
T61041369761-01-2
Cerdulatinib hydrochloride (PRT2070 hydrochloride) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively. Also inhibits 19 other tested kinases with IC50 less than 200 nM.
- $31
Size
QTY
IM-54
IM54, IM 54
T24160861891-50-1
IM-54 is a cell-permeable, effective, and selective necrosis inhibitor.
- $52
Size
QTY
PRT062607 hydrochloride
PRT062607 (P505-15, BIIB057) HCl, P505-15 Hydrochloride
T26961370261-97-4
PRT062607 hydrochloride (P505-15 Hydrochloride) is a selective inhibitor of Syk (IC50: 1 nM). It displays at least 80-fold selectivity for Syk over other kinases.
- $55
Size
QTY
(E/Z)-Necrosulfonamide Cited
T7129432531-71-0
(E/Z)-Necrosulfonamide is a novel inhibitor of MLKL.
- $33
Size
QTY
CitedURMC-099
T60571229582-33-5
URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19/42/14/150 nM, for MLK1/MLK2/MLK3/DLK), and also inhibits LRRK2 activity (IC50: 11 nM).
Aurora KinaseAutophagyBcr-AblCDKc-Met/HGFRDNA AlkylationIGF-1RLRRK2MEKMLKROCKSGKSrcSykTrk receptorVEGFR
- $52
Size
QTY
Select Batch
Purity:98.61%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | MLKL-IN-2 is an MLKL inhibitor with potential tumorigenic activity for the study of cellular necrosis-related diseases. |
| Molecular Weight | 423.51 |
| Formula | C26H25N5O |
| Cas No. | 899759-16-1 |
| Smiles | CN1CCN(CC1)c1ccc(nn1)-c1cccc(NC(=O)c2ccc3ccccc3c2)c1 |
| Relative Density. | no data available |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
| Solubility Information | DMSO: 4.23 mg/mL (10 mM), Sonication is recommended.  | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy MLKL-IN-2 | purchase MLKL-IN-2 | MLKL-IN-2 cost | order MLKL-IN-2 | MLKL-IN-2 chemical structure | MLKL-IN-2 formula | MLKL-IN-2 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.